申请人:Meiji Seika Kaisha, Ltd.
公开号:US06713473B1
公开(公告)日:2004-03-30
A compound represented by the formula (I) [A represents a 5- to 7-membered hydrocarbon ring group; L represents —NR3—CO—, —CO—NR3— and the like (R3 represents a hydrogen atom, a lower alkyl group, a lower acyl group and the like); M represents an alkylene linking group (a carbon atom constituting the carbon chain may be replaced with a nitrogen atom, an oxygen atom and the like); X represents —S—, —O—, —NR4—, —NR5—CO— and the like (R4 and R5 represent a hydrogen atom, a lower alkyl group and the like) or a single bond; Y represents an alkyl group, an aryl group, an amino group, an aromatic heterocyclic group and the like; R1 represents a lower alkyl group, a lower alkenyl group, a lower alkynyl group or a lower acyl group; and R21, R22 and R23 represent a hydrogen atom, a hydroxyl group, a lower alkyl group and the like] or a salt thereof. The compound is useful as an active ingredient of medicaments for diseases in which neuropeptide Y is involved, ingestion control for hyperphagia and the like.
化合物的化学式为(I) [其中,A代表5到7个成员的烃环基团;L代表—NR3—CO—,—CO—NR3—等(其中R3代表氢原子,低级烷基基团,低级酰基基团等);M代表一种烷基连接基团(碳链中的碳原子可被氮原子,氧原子等替换);X代表—S—,—O—,—NR4—,—NR5—CO—等(其中R4和R5代表氢原子,低级烷基基团等)或者单键;Y代表烷基基团,芳基基团,氨基基团,芳香族杂环基团等;R1代表低级烷基基团,低级烯基基团,低级炔基基团或者低级酰基基团;R21、R22和R23代表氢原子,羟基,低级烷基基团等] 或其盐。该化合物可作为治疗涉及神经肽Y的疾病、控制过度进食等药物的活性成分。